Cargando…
Cell-Free DNA in Blood Reveals Significant Cell, Tissue and Organ Specific injury and Predicts COVID-19 Severity
COVID-19 primarily affects the lungs, but evidence of systemic disease with multi-organ involvement is emerging. Here, we developed a blood test to broadly quantify cell, tissue, and organ specific injury due to COVID-19, using genome-wide methylation profiling of circulating cell-free DNA in plasma...
Autores principales: | Cheng, Alexandre Pellan, Cheng, Matthew Pellan, Gu, Wei, Lenz, Joan Sesing, Hsu, Elaine, Schurr, Erwin, Bourque, Guillaume, Bourgey, Mathieu, Ritz, Jerome, Marty, Francisco, Chiu, Charles Y., Vinh, Donald Cuong, Vlaminck, Iwijn De |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402071/ https://www.ncbi.nlm.nih.gov/pubmed/32766608 http://dx.doi.org/10.1101/2020.07.27.20163188 |
Ejemplares similares
-
Cell-free DNA tissues of origin by methylation profiling reveals significant cell, tissue, and organ-specific injury related to COVID-19 severity
por: Cheng, Alexandre Pellan, et al.
Publicado: (2021) -
Cell-free DNA profiling informs all major complications of hematopoietic cell transplantation
por: Cheng, Alexandre Pellan, et al.
Publicado: (2022) -
A systems biology approach identifies candidate drugs to reduce mortality in severely ill patients with COVID-19
por: Fava, Vinicius M., et al.
Publicado: (2022) -
Separating the signal from the noise in metagenomic cell-free DNA sequencing
por: Burnham, Philip, et al.
Publicado: (2020) -
Biopsy‐free screening for glioma
por: Cheng, Alexandre Pellan, et al.
Publicado: (2018)